ÂÜÀòÂÒÂ×

The Research and Development Team at Biohaven Pharmaceuticals focuses on the discovery and development of innovative therapies targeting the glutamatergic system. Comprised of experts in various scientific and medical disciplines, the team conducts preclinical and clinical research, designs and analyzes experiments, and ensures compliance with regulatory standards to advance clinical-stage compounds from concept to treatment. Their collaborative efforts aim to enhance understanding of neurological disorders and pave the way for effective new therapies.